fda glp-1 Approves Generic Version of Liraglutide Injection, a for Weight Loss GLP-1 Meds Linked to 265
Description
It never touched anything about my eating, she says
Researchers also considered evidence showing that GLP-1 receptors are present in brain regions involved in reward processing
doi: 10.1056/NEJMoa2108269 62 Effect of Liraglutide on Body Weight in Non-Diabetic Obese Subjects or Overweight Subjects With Co-Morbidities: SCALE-Obesity and Pre-Diabetes (2011)
Retatrutide remains an experimental medication still in Phase 3 clinical trials
